GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » SIGA Technologies Inc (NAS:SIGA) » Definitions » EV-to-EBIT

SIGA (SIGA Technologies) EV-to-EBIT : 5.70 (As of Jul. 09, 2025)


View and export this data going back to 1997. Start your Free Trial

What is SIGA Technologies EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, SIGA Technologies's Enterprise Value is $321.9 Mil. SIGA Technologies's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 was $56.5 Mil. Therefore, SIGA Technologies's EV-to-EBIT for today is 5.70.

The historical rank and industry rank for SIGA Technologies's EV-to-EBIT or its related term are showing as below:

SIGA' s EV-to-EBIT Range Over the Past 10 Years
Min: -45.51   Med: 3.28   Max: 81.14
Current: 5.7

During the past 13 years, the highest EV-to-EBIT of SIGA Technologies was 81.14. The lowest was -45.51. And the median was 3.28.

SIGA's EV-to-EBIT is ranked better than
90.64% of 684 companies
in the Drug Manufacturers industry
Industry Median: 17.605 vs SIGA: 5.70

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. SIGA Technologies's Enterprise Value for the quarter that ended in Mar. 2025 was $229.8 Mil. SIGA Technologies's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 was $56.5 Mil. SIGA Technologies's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2025 was 24.57%.


SIGA Technologies EV-to-EBIT Historical Data

The historical data trend for SIGA Technologies's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SIGA Technologies EV-to-EBIT Chart

SIGA Technologies Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.80 5.06 10.23 2.97 3.92

SIGA Technologies Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.80 4.23 3.66 3.92 4.07

Competitive Comparison of SIGA Technologies's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, SIGA Technologies's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SIGA Technologies's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, SIGA Technologies's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where SIGA Technologies's EV-to-EBIT falls into.


;
;

SIGA Technologies EV-to-EBIT Calculation

SIGA Technologies's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=321.944/56.453
=5.70

SIGA Technologies's current Enterprise Value is $321.9 Mil.
SIGA Technologies's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $56.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SIGA Technologies  (NAS:SIGA) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

SIGA Technologies's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2025 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2025 ) =EBIT / Enterprise Value (Q: Mar. 2025 )
=56.453/229.78468
=24.57 %

SIGA Technologies's Enterprise Value for the quarter that ended in Mar. 2025 was $229.8 Mil.
SIGA Technologies's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $56.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SIGA Technologies EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of SIGA Technologies's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


SIGA Technologies Business Description

Traded in Other Exchanges
N/A
Address
31 East 62nd Street, New York, NY, USA, 10065
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.
Executives
Evan A. Knisely director C/O SIGA TECHNOLOGIES, INC., 31 EAST 62ND STREET, NEW YORK NY 10065
Jay Varma director C/O SIGA TECHNOLOGIES, INC., 31 EAST 62ND STREET, NEW YORK NY 10065
Ford Harold Eugene Jr. director 4921 WILLIAM ARNOLD ROAD, MEMPHIS TN 38117
James Antal director 30952 STEEPLECHASE DRIVE, SAN JUAN CAPISTRANO CA 92675
Holly L. Phillips director C/O SIGA TECHNOLOGIES, INC., 31 EAST 62ND STREET, NEW YORK NY 10065
Gary J. Nabel director C/O SIGA TECHNOLOGIES, INC., 31 EAST 62ND STREET, NEW YORK NY 10065
Julian Nemirovsky director 35 EAST 62ND STREET, NEW YORK NY 10065
Edward P. Taibi director 35 EAST 62ND STREET, NEW YORK NY 10065
Jaymie A Durnan director C/O SIGA TECHNOLOGIES, INC.,, 31 EAST 62ND STREET, NEW YORK NY 10065
Gomez Phillip Louis Iii officer: Chief Executive Officer 7220 VAN NESS COURT, MCLEAN VA 22101
Daniel J Luckshire officer: Executive VP & CFO C/O SIGA TECHNOLOGIES, INC., 35 EAST 62ND STREET, NEW YORK NY 10065
Paul G Savas director 35 EAST 62ND STREET, NEW YORK NY 10021
Julie Kane director 77 BEALE ST, P.O. BOX 770000, SAN FRANCISCO CA 94177
Dennis E Hruby officer: Chief Scientific Officer SIGA TECHNOLOGIES, INC., 420 LEXINGTON AVENUE, SUITE 601, NEW YORK NY 10170
Michael J Bayer director 1100 N GLEBE ROAD, ARLINGTON VA 22201